Can Psilocybin Help People Quit Smoking? Let’s Look at This Study.

Most people who smoke want to stop. Many have already tried. And most quit attempts even with patches, gum, or prescription medication come apart within six months. That gap between wanting to quit and staying quit is why a study published in March 2026 has drawn so much attention.

Researchers at Johns Hopkins followed 82 adult smokers. Everyone in the study received the same thing first: a 13-week structured counseling program built around understanding their smoking and planning for the hard moments. Then participants were randomly assigned to one of two additional treatments. Half received a single supervised dose of psilocybin the, active compound in psychedelic mushrooms on their quit day, in a quiet room with trained facilitators present for the entire eight- to nine-hour session. The other half started a standard 8- to 10-week course of the nicotine patch.

Six months later, 41% of the psilocybin group stopped smoking completely, compared with 10% of the patch group. These weren't self-reports taken on trust; abstinence was confirmed with breath and urine testing. No serious side effects were linked to either treatment. During the psilocybin sessions, blood pressure and heart rate rose temporarily, and headaches were common afterward.

Those numbers are striking, and they deserve an honest look at what the study can and cannot tell us.

Everyone involved knew which treatment they were getting, you cannot hide a psychedelic experience so some of the benefit may reflect belief and expectation rather than the drug itself, a sort of placebo effect. The psilocybin group also spent nearly twice as many hours with the research team, and attention and support alone help people quit. The study was small, which means the true size of the benefit is still uncertain. And the participants were unusually healthy, highly educated, mostly white, and nearly two-thirds had used a psychedelic before, not a group that looks much like the average person trying to quit. Finally, the comparison was against the nicotine patch alone, which is one of the weaker proven options rather than the strongest.

What this means practically: psilocybin remains investigational. It is not legally available for smoking cessation, and it is not something we or any clinic can offer outside a research trial. If you are working on quitting now, the evidence-backed path is still a combination of proven medication and real behavioral support and this study is a good reminder that the counseling half of that pair is not optional.

The more interesting takeaway may be conceptual. Psilocybin does not act on nicotine receptors at all. If it helps, it likely does so by shifting how a person sees themselves and their relationship with smoking. That is worth paying attention to, whatever comes of the drug itself.

Johnson MW, Naudé GP, Hendricks PS, et al. Psilocybin or nicotine patch for smoking cessation: a pilot randomized clinical trial. JAMA Netw Open. 2026;9(3):e260972. doi:10.1001/jamanetworkopen.2026.0972

This article is for general education and is not medical advice. If you are considering a change to your treatment, talk with your clinician.